Atai Life Sciences N.V. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ATAI Nasdaq 2830 atai.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Atai Life Sciences N.V.

atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies - Nov 5th, 2025 5:00 am
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares - Oct 20th, 2025 3:29 pm
atai Life Sciences (ATAI) Upgraded to Buy: Here's Why - Oct 20th, 2025 10:00 am
Atai Life Sciences (ATAI): Evaluating Valuation After FDA Breakthrough Therapy Designation for BPL-003 - Oct 18th, 2025 9:11 am
Why Atai Life Sciences Stock Was So Lively This Week - Oct 17th, 2025 6:06 am
atai Life Sciences Announces Pricing of Public Offering of Common Shares - Oct 16th, 2025 8:31 pm
atai Life Sciences Announces Proposed Public Offering of Common Shares - Oct 16th, 2025 2:12 pm
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression - Oct 16th, 2025 2:10 pm
Why Atai Life Sciences (ATAI) Is in Focus After Positive Depression Data and $239M Shelf Registration Filing - Oct 2nd, 2025 9:37 am
atai and Beckley’s psychedelic advances to pivotal TRD trial - Sep 24th, 2025 5:09 am
Atai Life Sciences N.V. (ATAI) Advances Psychedelic Therapies for Mental Health, Drawing Investor Spotlight - Sep 23rd, 2025 5:21 pm
Why Atai Life Sciences Stock Crushed It on Tuesday - Sep 23rd, 2025 3:51 pm
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients - Sep 23rd, 2025 12:50 pm
Sector Update: Health Care Stocks Advance Premarket Tuesday - Sep 23rd, 2025 7:19 am
Atai, Beckley Report Positive Phase 2a Results for Intranasal BPL-003 in Treatment-Resistant Depression - Sep 23rd, 2025 6:02 am
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression - Sep 23rd, 2025 5:00 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Sep 21st, 2025 7:06 pm
Atai Life Sciences (ATAI): How NIDA’s $11.4M Grant Shapes the Valuation Outlook - Sep 20th, 2025 6:08 am
H.C. Wainwright Affirms ‘Buy’ Rating on Atai Life Sciences N.V. (ATAI) on Psychedelic Prospects - Sep 20th, 2025 12:43 am
Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year? - Sep 19th, 2025 7:40 am